Cargando…

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma

Background: Stomach adenocarcinoma (STAD) is one of the most common tumors. Tumor mutation burden (TMB) has been linked to immunotherapy response. We wanted to see if there was any link between TMB and cancer prognosis. Methods: The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Min, Huang, Yongbiao, Peng, Xiaohong, Li, Xiaoyu, Luo, Na, Zhu, Wenjun, Yang, Feng, Chen, Ziqi, Ma, Shengling, Zhang, Yuanyuan, Li, Qianxia, Hu, Guangyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983817/ https://www.ncbi.nlm.nih.gov/pubmed/35399509 http://dx.doi.org/10.3389/fcell.2022.790920

Ejemplares similares

Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma
por: Luo, Na, et al.
Publicado: (2022)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma
por: Lyu, Zejian, et al.
Publicado: (2022)

Development of a Novel Prognostic Model of Glioblastoma Based on m6A-Associated Immune Genes and Identification of a New Biomarker
por: Luo, Na, et al.
Publicado: (2022)

Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus
por: Zeng, Yongji, et al.
Publicado: (2023)

Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability
por: Yang, Dongdong, et al.
Publicado: (2021)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

PLXNC1: A Novel Potential Immune-Related Target for Stomach Adenocarcinoma
por: Ni, Zhizhan, et al.
Publicado: (2021)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
por: Jia, Zeming, et al.
Publicado: (2022)

Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma
por: Pan, Jingjing, et al.
Publicado: (2022)

Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
por: Meijing, Zhang, et al.
Publicado: (2022)

Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
por: Huo, Chen, et al.
Publicado: (2021)

Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma
por: Zhou, Haiting, et al.
Publicado: (2023)

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2021)

P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
por: Zhao, Qi, et al.
Publicado: (2021)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma
por: Zhu, Wenjun, et al.
Publicado: (2023)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
por: Jiang, Wei, et al.
Publicado: (2021)

Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
por: Geng, Wei, et al.
Publicado: (2021)

Prognostic Value of Genomic Instability of m(6)A-Related lncRNAs in Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2022)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data
por: Zou, Qiyuan, et al.
Publicado: (2021)

A Novel Early-Stage Lung Adenocarcinoma Prognostic Model Based on Feature Selection With Orthogonal Regression
por: Tang, Binhua, et al.
Publicado: (2021)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer
por: Zhang, Ming, et al.
Publicado: (2020)

Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma
por: Zhang, Xu, et al.
Publicado: (2023)

Identification and verification of a prognostic signature based on a miRNA–mRNA interaction pattern in colon adenocarcinoma
por: Zhao, Qiwu, et al.
Publicado: (2023)

The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
por: Tan, Shuzhen, et al.
Publicado: (2021)

Helicobacter pylori regulates stomach diseases by activating cell pathways and DNA methylation of host cells
por: Xi, Yue, et al.
Publicado: (2023)

Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer
por: Wang, Dan, et al.
Publicado: (2022)

An update on methods for detection of prognostic and predictive biomarkers in melanoma
por: Adeuyan, Oluwaseyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0v5qfu3rboclhlm03pjfrfd2mr